Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management …

SE Lipshultz, MJ Adams, SD Colan, LS Constine… - Circulation, 2013 - Am Heart Assoc
1928 Circulation October 22, 2013 mental health, functional status, activity limitations,
cancerrelated pain, and cancer-related anxiety) declined moderately to severely in 44%. 5 …

Psychosocial functioning and risk factors among siblings of children with cancer: An updated systematic review

KA Long, V Lehmann, CA Gerhardt… - Psycho …, 2018 - Wiley Online Library
Objectives Siblings' psychosocial adjustment to childhood cancer is poorly understood. This
systematic review summarizes findings and limitations of the sibling literature since 2008 …

[HTML][HTML] Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors

N Bansal, MJ Adams, S Ganatra, SD Colan… - Cardio-Oncology, 2019 - Springer
Cancer diagnostics and therapies have improved steadily over the last few decades,
markedly increasing life expectancy for patients at all ages. However, conventional and …

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective …

SE Lipshultz, RE Scully, SR Lipsitz, SE Sallan… - The lancet …, 2010 - thelancet.com
Background Doxorubicin chemotherapy is associated with cardiomyopathy. Dexrazoxane
reduces cardiac damage during treatment with doxorubicin in children with acute …

Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment

S Raj, VI Franco, SE Lipshultz - Current treatment options in …, 2014 - Springer
Opinion statement Anthracyclines have been widely used in children and adults to treat
hematologic malignancies, soft-tissue sarcomas, and solid tumors. However, anthracyclines …

Treatment-related cardiotoxicity in survivors of childhood cancer

SE Lipshultz, TR Cochran, VI Franco… - Nature reviews Clinical …, 2013 - nature.com
Abstract Treatment advances and higher participation rates in clinical trials have rapidly
increased the number of survivors of childhood cancer. However, chemotherapy and …

Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy

SE Lipshultz, DC Landy, G Lopez-Mitnik… - Journal of Clinical …, 2012 - ascopubs.org
Purpose To determine whether cardiovascular abnormalities in childhood cancer survivors
are restricted to patients exposed to cardiotoxic anthracyclines and cardiac irradiation and …

Anthracycline-associated cardiotoxicity in survivors of childhood cancer

BH Trachtenberg, DC Landy, VI Franco, JM Henkel… - Pediatric …, 2011 - Springer
Anthracycline chemotherapeutic agents are widely used to treat childhood cancers, helping
to create an increasing population of childhood cancer survivors. Cardiac complications can …

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

D Harake, VI Franco, JM Henkel, TL Miller… - Future …, 2012 - Taylor & Francis
Advances in cancer treatment have greatly improved survival rates of children with cancer.
However, these same chemotherapeutic or radiologic treatments may result in long-term …

Cardiovascular disease in adult survivors of childhood cancer

SE Lipshultz, VI Franco, TL Miller… - Annual review of …, 2015 - annualreviews.org
Treatment advances have increased survival in children with cancer, but subclinical,
progressive, irreversible, and sometimes fatal treatment-related cardiovascular effects may …